CVS Health Corporation
CVS
$64.50
$0.841.32%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 8.34B | 8.63B | 2.97B | 4.09B | 4.31B |
| Total Depreciation and Amortization | 4.37B | 4.28B | 4.20B | 4.18B | 4.22B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 701.00M | 855.00M | 1.46B | 1.17B | 824.00M |
| Change in Net Operating Assets | 15.00M | 348.00M | 11.89B | 10.61B | 6.82B |
| Cash from Operations | 13.43B | 14.11B | 20.52B | 20.05B | 16.18B |
| Capital Expenditure | -3.03B | -2.81B | -2.84B | -2.66B | -2.73B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -16.61B | -16.50B | -16.49B | -7.23B | -139.00M |
| Divestitures | -- | 679.00M | 694.00M | -1.25B | -1.25B |
| Other Investing Activities | -1.25B | -1.14B | -1.16B | -433.00M | -932.00M |
| Cash from Investing | -20.89B | -19.77B | -19.80B | -11.57B | -5.05B |
| Total Debt Issued | 16.10B | 15.90B | 16.90B | 5.95B | -- |
| Total Debt Repaid | -8.17B | -7.75B | -9.47B | -4.56B | -4.21B |
| Issuance of Common Stock | 277.00M | 283.00M | 323.00M | 350.00M | 551.00M |
| Repurchase of Common Stock | -2.19B | -3.72B | -3.73B | -3.86B | -3.87B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.13B | -3.07B | -3.02B | -2.96B | -2.91B |
| Other Financing Activities | -201.00M | -170.00M | -61.00M | -58.00M | -79.00M |
| Cash from Financing | 2.68B | 1.47B | 947.00M | -5.14B | -10.52B |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.78B | -4.19B | 1.66B | 3.34B | 614.00M |
